Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the pivotal Phase 3 study design following successful alignment with the U.S. Food and Drug Administration (FDA) on ION582, an ...
Praxis recognized $0.3 million in collaboration revenue during the three months ended September 30, 2024, compared to $0.5 ...
RideApart on MSN55m
Honda Unveils V3 Engine With Electric Turbocharger, Shocking World FirstIt's not that I think Honda is boring, but this certainly isn't the brand's traditional safe play. I won't go as far as to say Honda is boring, but if it discontinues the CBR600RR, I will. The fact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback